A research partnership brings gene editing promise to eye disease - Morgridge Institute for Research
One of the first frontiers of CRISPR gene editing is targeting diseases related to the eye. A diverse Morgridge and UW-Madison team is working to make future applications precise, safe and reproducible.
Source: morgridge.org